Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis

American Journal of Gastroenterology

Volumn 97, Issue 3, 2002, Pages 679-689

  Stio, Maria ^a   Treves, Cristina ^b   Celli, Alessandra ^b   Tarantino, Ottaviano ^b   D'Albasio, Giuseppe ^b   Bonanomi, Andrea Giovanni ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLOSPORIN A; LEXACALCITOL; PHYTOHEMAGGLUTININ; SEOCALCITOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS;

ADULT; CALCITRIOL; CELL PHYSIOLOGY; COLITIS, ULCERATIVE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; T-LYMPHOCYTES; VITAMIN D;

EID: 0036126265     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04111-9     Document Type: Article

References (58)

1. 3
2. Vitamine D et système immunitare
3. 3 induces differentiation of human myeloid leukemia cells
4. 3
5. 3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells
6. 3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation
7. 3 - Specific inhibition at the level of messenger RNA
8. 3 receptor in the immune system
9. 3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation
10. Mediators of immunity: Lymphokines and monokines
11. T-cell growth factor and the culture of cloned functional T cells
12. 3
13. T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriol
14. 3
15. 3-treated monocytes
16. Vitamin D differentially regulates B7.1 and B/.2 expression on human peripheral blood monocytes
17. 3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis
18. 3 attenuates the expression of experimental murine lupus of MRL/1 mice
19. 3 prolongs skin graft survival in mice
20. 3 as a dose-reducing agent for cyclosporine and FK 506
21. Mechanism of action of cyclosporin A: Inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas
22. Cyclosporine A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2
23. Inhibition of T-cell activity by cyclosporin A
24. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription
25. 3 potentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patients
26. 3 on the induction of experimental autoimmune thyroiditis
27. Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat
28. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: Synergy with cyclosporin
29. 3 in combination with cyclosporin A
30. 3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo
31. 3
32. Preliminary report: Cyclosporin in treatment of severe active ulcerative colitis
33. Alterations of the immune system in ulcerative colitis and Crohn's disease
34. Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients
35. 3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis
36. Activation of T-lymphocytes in Crohn disease and in ulcerative hemorrhagic rectocolitis. Therapeutic implications
37. Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis
38. Immunologic mechanisms in intestinal disease
39. The immunologic basis of inflammatory bowel disease
40. 3 analogue (EB 1089) inhibits in vitro cellular proliferation of human colon cancer cells
41. A phase I study of the vitamin D analogues EB 1089 in patients with advanced breast and colorectal cancer
42. 3 analogues: A novel class of potent regulators of cell growth and immune responses
43. 3 analogue (KH1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells
44. 3, KH1060
45. 3
46. Combination of Cyclosporin A and calcitriol in the treatment of adjuvant arthritis
47. Cortisone in ulcerative colitis. Final report on a therapeutic trial
48. 3 analogs correlates with inhibition of DNA synthesis and reduced calmodulin concentration
49. Cyclosporin A binding to calmodulin: A possible site of action on T lymphocytes
50. Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation
51. 3-regulated binding of nuclear proteins to a c-myc intron element
52. 3 regulates c-myc mRNA levels in tonsillar T lymphocytes
53. Increased expression of C-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis
54. NF-Atp: A transcription factor required for the coordinate induction of several cytokine genes
55. Signal transmission between the plasma membrane and nucleus of T lymphocytes
56. Transcriptional regulation of the IL-2 gene
57. Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import
58. 3-mediated effects